Oxford BioDynamics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

AIM:OBD Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
10 Apr 25BuyUK£14,955Peter PreslandIndividual3,398,553UK£0.0044
01 Apr 25BuyUK£3,560Paul StockdaleIndividual791,176UK£0.0045
01 Apr 25SellUK£3,560Paul StockdaleIndividual791,176UK£0.0045
28 Nov 24BuyUK£645David Mark HolbrookIndividual51,640UK£0.012
28 Nov 24BuyUK£2,730Thomas GuielIndividual218,370UK£0.012
28 Nov 24BuyUK£2,525Alexandre AkoulitchevIndividual202,034UK£0.012
28 Nov 24BuyUK£6,558Jon Anthony BurrowsIndividual524,604UK£0.012
28 Nov 24BuyUK£2,142Ewan HunterIndividual171,353UK£0.012
28 Nov 24BuyUK£2,338Paul StockdaleIndividual187,041UK£0.012
28 Nov 24BuyUK£1,276Matthew WakefieldIndividual102,043UK£0.012
28 Oct 24BuyUK£645David Mark HolbrookIndividual49,653UK£0.013
28 Oct 24BuyUK£2,399Thomas GuielIndividual184,545UK£0.013
28 Oct 24BuyUK£2,525Alexandre AkoulitchevIndividual194,263UK£0.013
28 Oct 24BuyUK£6,405Jon Anthony BurrowsIndividual492,682UK£0.013
28 Oct 24BuyUK£2,142Ewan HunterIndividual164,763UK£0.013
28 Oct 24BuyUK£2,338Paul StockdaleIndividual179,847UK£0.013
28 Oct 24BuyUK£1,276Matthew WakefieldIndividual98,118UK£0.013

Insider Trading Volume

Insider Buying: OBD insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of OBD?
Owner TypeNumber of SharesOwnership Percentage
Public Companies00%
Private Companies2,934,3940.136%
Hedge Funds251,876,17811.7%
Individual Insiders408,497,08718.9%
Institutions1,492,790,76669.2%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 527.7%.


Top Shareholders

Top 25 shareholders own 96.32% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.9%
Stephen Diggle
251,876,178UK£818.6k818%no data
12.9%
Vulpes Investment Management Private Limited
251,876,178UK£818.6k0%1.9%
11.8%
M. D. Barnard & Co. Ltd., Asset Management Arm
230,738,105UK£749.9k3,680%0.52%
8.51%
Hargreaves Lansdown Asset Management Ltd.
166,661,240UK£541.6k535%no data
7.41%
Unicorn Asset Management Ltd.
145,131,526UK£471.7k0%0.09%
6.57%
Sankofa Investment Management (Guernsey) Limited
128,521,716UK£417.7k0%13.79%
3.94%
Aberdeen Group Plc
77,171,910UK£250.8k242%no data
3.79%
Arbuthnot Latham & Co. Limited, Asset Management Arm
74,240,012UK£241.3k183%1.3%
3.07%
William Salomon
60,000,000UK£195.0k0%no data
2.89%
Chelverton Asset Management Limited
56,650,000UK£184.1k641%0.02%
2.84%
Barclays Bank PLC, Wealth and Investment Management Division
55,660,945UK£180.9k136%no data
2.32%
Jefferies Group LLC, Asset Management Arm
45,400,000UK£147.5k0%0.02%
2.04%
Citigroup Inc.,Banking and Securities Investments
40,000,000UK£130.0k0%no data
2.01%
IG Group Holdings Plc, Asset Management Arm
39,294,084UK£127.7k2,870%0.01%
1.96%
Patronus Partners Limited
38,461,721UK£125.0k648%0.65%
1.94%
Zeus Capital Limited, Asset Management Arm
38,000,000UK£123.5k3,320%0.89%
1.48%
Cantor Fitzgerald Asset Management
28,880,000UK£93.9k-28.1%no data
1.11%
Henderson Rowe Limited
21,793,134UK£70.8k0%0.85%
1.1%
Intrinsic Capital LLP
21,532,828UK£70.0k1,300%1.81%
1.07%
Goy Harris Cartwright
21,011,859UK£68.3k0%0.28%
1.07%
Killik Asset Management
20,870,027UK£67.8k544%no data
1.02%
Brewin Dolphin Limited
20,025,000UK£65.1k0%no data
0.94%
TrinityBridge Limited
18,439,364UK£59.9k4,440%no data
0.86%
HBOS Investment Fund Managers Limited
16,812,698UK£54.6k183%no data
0.84%
Fidelity International Ltd
16,460,014UK£53.5k802%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/29 04:52
End of Day Share Price 2025/05/29 00:00
Earnings2024/09/30
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Oxford BioDynamics Plc is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tara RaveendranShore Capital Group Ltd
null nullStifel, Equities Research
Christian GlennieStifel, Equities Research